Public Profile

MedReleaf Corp.

MedReleaf Corp., a leading player in the cannabis industry, is headquartered in California and operates across several key regions in North America. Founded in 2013, the company has established itself as a pioneer in the production of high-quality medical and recreational cannabis products. MedReleaf is renowned for its innovative cultivation techniques and a diverse range of premium cannabis strains, including both flower and oil products. Their commitment to quality and consistency sets them apart in a competitive market. With a strong focus on research and development, MedReleaf has achieved significant milestones, including various industry awards that underscore its market position. As a trusted name in the cannabis sector, MedReleaf continues to lead the way in providing safe and effective cannabis solutions for consumers.

DitchCarbon Score

How does MedReleaf Corp.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

33

Industry Benchmark

MedReleaf Corp.'s score of 23 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.

17%

Let us know if this data was useful to you

MedReleaf Corp.'s reported carbon emissions

MedReleaf Corp., headquartered in Canada, currently does not have available data on its carbon emissions, as no specific emissions figures have been reported. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the context of the cannabis industry, many companies are increasingly focusing on sustainability and reducing their carbon footprints, but specific commitments or initiatives from MedReleaf Corp. remain unspecified. As the industry evolves, it is anticipated that MedReleaf may adopt more defined climate strategies and targets in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. MedReleaf Corp.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for MedReleaf Corp. is in CA, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

MedReleaf Corp. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Cronos Group Inc.

CA
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers